Revvity | PKI - Spese Operative

Prezzo Delle Azioni
87.32
Cambio Giornaliero
-1.00 -1.13%
Mensile
-5.20%
Annuale
-4.87%
Q2 Previsione
86.26




Spese Operative Cambiamento Data
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 423M 1.06B 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Organigram Holdings CAD 83.66M 24.44M 2025-12
Ovoca Bio EUR 1.16M 4.48M 2025-06
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.42B 4.84B 2025-12
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Tilray USD 237.52M 17.34M 2025-09
Waters USD 661.85M 1.67B 2025-12
Zealand Pharma A/S 775.97M 265.08M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09